Significant Ownership of Sofinnova Venture Partners X, L.P.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Sofinnova Venture Partners X, L.P. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Nathalie Auber - Nathalie Auber / Attorney-in-Fact
- Manager location
- Menlo Park, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Sofinnova Venture Partners X, L.P. and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Sofinnova Venture Partners X, L.P.
Significant Ownership of Sofinnova Venture Partners X, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | Class A Common Stock, $0.001 par value | 4% | $128,465,927 | 2,847,837 | Dr. Maha Katabi ("Katabi") | 10 Dec 2025 | ||
| JBIO | Jade Biosciences, Inc. | Common Stock, par value $0.0001 per share | 0.3% | $1,617,308 | 107,391 | Sofinnova Venture Partners X, L.P. ("SVP X") | 28 Apr 2025 |
Schedules 13D/G Reported by Sofinnova Venture Partners X, L.P.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.